A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)
view all Clinical Trials
The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.
For more information about this trial or to inquire about eligibility, email email@example.com or call 215-707-1359.